Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Reusable shopping bags encourage shoppers to buy produce -- and junk food?

  • Yes, it pays to win back lost customers

  • Can a humanlike figure actually harm a company?

  • Faced with limited choices, prisoners become entrepreneurs to meet their needs

  • Fewer women than men are shown online ads related to high-paying jobs

  • Adolescent exposure to e-cigarette tv ads increases likelihood of future use

  • Researchers learn to measure aging process in young adults

  • Brain imaging shows how children inherit their parents' anxiety

  • Life expectancy substantially lower with combination of diabetes, stroke or heart attack

  • Smartphones may be detrimental to learning process

  •